Medical Device Testing Market Size, Share and Trends 2026 to 2035

Revenue, 2025

USD 10.76 Bn

Forecast Year, 2035

USD 25.82 Bn

CAGR, 2026 - 2035

9.15%

Report Coverage

Global

What is the Medical Device Testing Market Size?

The global medical device testing market size is calculated at USD 10.76 billion in 2025 and is predicted to increase from USD 11.77 billion in 2026 to approximately USD 25.82 billion by 2035, expanding at a CAGR of 9.15% from 2026 to 2035. Stringent regulations and rising demand for safe, high-quality medical devices also drive the market.

Medical Device Testing Market Key Takeaways

• The global medical device testing market was valued at USD 10.76 billion in 2025.
• It is projected to reach USD 25.82 billion by 2035.
• The market is expected to grow at a CAGR of 9.15% from 2026 to 2035.
• Asia Pacific dominated the market with the largest revenue share of 42% in 2025.
• North America is estimated to be the fastest-growing during the forecast period of 2026 to 2035.
• The biocompatibility tests segment dominated the market in 2025.
• The chemistry tests segment is expected to expand at the fastest CAGR of 9.73% during the forecast period.
• The clinical segment led the market with the major revenue share of 60% in 2025.
• The preclinical segment is the fastest-growing during the forecast period.

Market Overview

Medical device testing refers to the evaluation of medical devices for safety, quality, performance, and regulatory compliance, both before and after commercialization. Testing must be done to ensure proper functioning of the devices and adherence to strict healthcare standards. The demand for enhanced medical technologies, rising healthcare expenditure, and heightened patient safety awareness is driving this market. The rising occurrence of chronic diseases and the need for fresh equipment for diagnosis and treatment are urging manufacturers to invest in next-generation testing solutions, adding to the growth of the medical device testing market.

How is AI Impacting the Market?

It is now more crucial than ever to go beyond automation and begin utilizing AI and ML for medical device testing since the expectations on testing and reliability towards delivery teams have grown significantly over time. Test cases that take into account a variety of characteristics, including functionality, scalability, coverage, and loading, may be automatically produced with the use of AI technologies. AI-driven test controllers may be used to detect test case failures and perform remediation procedures (as well as cover numerous regression cycles) in line with the kind of fault discovered, eliminating the need to run tests and manually resolve issues. When AI is used, the automation coverage is increased by around 30%.

Medical Device Testing Market Growth Factors

• Strict regulatory requirements from agencies such as the FDA and EMA are driving the need for extensive pre-market and post-market medical device testing.
• Rapid adoption of advanced and connected medical devices is increasing the complexity and volume of required performance and safety testing.
• Growing emphasis on patient safety and product quality assurance is pushing manufacturers to invest more in rigorous testing protocols.
• Rising prevalence of chronic diseases and an aging global population is increasing demand for medical devices and associated testing services.
• Technological advancements such as AI-based testing, automation, and simulation tools are improving testing efficiency and expanding market capabilities.
• Expansion of medical device manufacturing in emerging economies is increasing demand for local and global compliance testing services.
• Increasing outsourcing of testing activities to third-party laboratories is reducing costs and improving regulatory compliance for manufacturers.

Major Trends

• Elevated IoMT Cybersecurity Protocols: The proliferation of the internet of medical things (IoMT) has necessitated rigorous cybersecurity validation for connected life-critical devices, such as pacemakers and insulin pumps. Manufacturers are prioritizing data integrity and threat-mitigation testing to safeguard patient privacy and ensure device resilience against evolving cyber threats.
• Life-Cycle Regulatory Compliance: Stringent global frameworks, including the EU MDR/IVDR and FDA Section 524B, now mandate comprehensive, continuous testing throughout the product lifecycle. This shift requires persistent post-market surveillance and documentation to maintain market access under intensified scrutiny.
• Deployment of Digital Twin Simulations: To optimize R&D efficiency, the industry is increasingly adopting "digital twins", virtual prototypes that allow for high-fidelity performance and reliability testing in a simulated environment. This approach significantly compresses development cycles and reduces material waste by validating designs before physical production.
• Strategic Outsourcing to Specialized CROs: Escalating technical complexity and the capital-intensive nature of advanced testing infrastructure are driving manufacturers to outsource end-to-end testing to specialized Contract Research Organizations (CROs). This allows firms to leverage expert material characterization and sterilization validation while accelerating time-to-market.

Medical Device Testing Market Outlook

• Global Expansion: The expansion led by stringent regulations, technological advancements like AI and IoT, and the rising demand for safer, more reliable devices. In March 2024, Stryker expanded its prototype and testing facility in India.
• Major Investor: Proov raised $10 million in Series A funding for its FDA-authorized at-home progesterone test strips.
• Startup Ecosystem: In May 2024, Achira secured Series B funding to extend its diagnostic medical devices for point-of-care screening, combining disposable components with cloud-connected scanners.

Market Scope

Market Dynamics

Driver

Complexity in product design

Medical devices require specialized testing techniques because they may have intricate software architectures. For medical devices, regulatory compliance is a key factor, and it must meet the standards set by regulatory bodies like the U.S. Food and Drug Administration (FDA) will perform as intended. Medical device testing helps with the evaluation of the performance, safety, and effectiveness of complex medical devices. These factors help the growth of the medical device testing market.

Restraint

Medical device testing risks

Risks of medical device testing include risks during scrapping, component failures, side effects, misuse by users, software bugs, rough handling during shipping, production process failure, and poor design. These factors can hamper the growth of the market. Data integrity or compromised privacy because of unauthorized access to device information or patients. Unauthorized outside parties exploit vulnerabilities and comprise device functions. For the medical device industry, cyber security risks and safety risks are a growing concern. These factors can restrict the growth of the medical device testing market.

Opportunity

Research & development

Integration of advanced technologies in medical devices may help the growth of the market. Advanced technologies like machine learning (ML), artificial intelligence (AI), and the Internet of Things (IoT) used in medical device testing can help the growth of the market. Advanced technologies used in medical device testing are helpful for patients and healthcare professionals by reducing healthcare costs, increasing access to medical services, and for remote patient monitoring. As medical devices and computers become smarter, smaller, and faster, the medical device testing industry and medical device industry are making medical practice easy for doctors, more effective for patients, and with low costs for the entire healthcare system. These factors help the growth of the medical device testing market.

Segment Insights

Service Type Insights

The Biocompatibility Tests Segment Held a 44% Share of the Market in 2025

The biocompatibility tests segment dominated the medical device testing market in 2025 with a 44% share, as it ensures the safety of all medical devices. These tests evaluate the reaction of medical devices with the human body and identify or mitigate risks such as toxicity, sensitization, irritation, and immune responses, thereby reducing product recalls and improving overall device safety and quality.

The chemistry tests segment is expected to grow at the fastest rate in the coming years, as they are used to determine and study the chemical components of medical devices. Chemical testing is a characterization of extracts and leachables that may be found in the human body during use of the device. The assessment is helpful for manufacturers to know if there is a potential toxicological risk and to make sure that strict rules and regulations are being followed and that hazardous substances are being applied.

The microbiology & sterility test segment is expected to grow at a notable rate over the forecast period due to the critical requirement that medical devices remain free from harmful microorganisms when they reach patients. These tests assess sterilization effectiveness, microbial contamination levels, and overall product sterility. The segment growth is also driven by the increasing demand for assured sterility in devices such as surgical instruments, cleaning equipment, and products that come into contact with sterile body tissues.

The package validation segment is sustainably growing, driven by increasing manufacturers' focus on ensuring packaging integrity. Package validation testing is designed to confirm that packaging systems effectively protect medical devices from moisture, particles, physical damage, and temperature variations. This makes it a key component of medical device quality assurance and a mandatory regulatory requirement in product development.

Phase Type Insights

The Clinical Segment Held a 60% Market Share in 2025

The clinical segment dominated the medical device testing market by holding a 60% share in 2025. This is because it evaluates device performance, effectiveness, and safety directly in humans. Clinical testing is a critical regulatory requirement that validates medical devices and generates essential real-world data through pilot studies, pivotal trials, and post-market surveillance to assess their functional performance in actual medical use.

The preclinical segment is the fastest-growing segment, as companies are increasingly focusing on early-stage testing of medical devices before human trials. In preclinical testing, device safety, functionality, durability, and biocompatibility are assessed in controlled laboratory environments using methods such as material testing, animal studies, computer simulations, mechanical performance testing, and bench testing to ensure regulatory readiness and reduce clinical risks.

The large animal research segment is experiencing notable growth due to the physiological and anatomical similarities of large animal models to humans, making them highly valuable for evaluating medical device performance under realistic biological conditions. These models are commonly used in biocompatibility studies, chemistry evaluations, microbiology and sterility testing, and assessments of implant performance, tissue response, durability, and potential complications before devices advance to clinical trials.

The small animal research segment is steadily growing, driven by its cost-effectiveness, ease of handling, and ability to generate rapid scientific data. Small animal models are widely used for biocompatibility testing, chemistry analysis, microbiological evaluations, and early-stage safety assessments, helping manufacturers meet regulatory requirements efficiently. Additionally, advancements in genetic engineering and disease modeling have increased the importance of small animal models in evaluating innovative medical technologies and supporting translational research.

Regional Insights

What is the Asia Pacific Medical Device Testing Market Size?

The Asia Pacific medical device testing market size is valued at USD 4.52 billion in 2025 and is expected to be worth around USD 11.01 billion by 2035 with a CAGR of 9.31% from 2026 to 2035.

What Made Asia Pacific the Dominant Region in the Medical Device Testing Market?

Asia Pacific dominated the medical device testing market by holding the largest share in 2025. This is mainly due to its rapid modernization of healthcare systems and rising regulatory requirements. With the increasing upsurge in domestic manufacturing of medical devices, demand for testing services is increasing to satisfy the quality, safety, and international standards demands. Ongoing developments in medical technology are further promoted by Favorable market conditions, government policies for medical technology innovation, and manufacturing.

• In March 2026, the Government of India announced that the total number of medical device manufacturers licensed in India is 4108, with various risk classifications. They vary from manufacturers of class A medical devices to class B medical devices, class C medical devices, class D medical devices, and some manufacturers make more than one class.
• In January 2024, the National Single Window System (NSWS) was launched by India for medical device management or clinical investigation in a move to streamline the import and testing of medical devices.
• In March 2024, Stryker launched a new facility for the life cycle testing of medical devices for lab expansion in India. This helps to develop medical technologies that comply with the highest regulatory standards and improve patient outcomes. This new lab has several features, including a talented team of microbiologists and engineers, the ability to conduct extensive microbiological testing to ensure the efficacy and safety of the medical devices, prototyping, and product assurance.

What Makes North America the Fastest-Growing Region in the Medical Device Testing Market?

North America is expected to grow at the fastest rate in the coming years due to its advanced healthcare infrastructure, stringent regulatory framework, and strong presence of medical device manufacturers. The growing adoption of innovative medical technologies, including implantable devices, digital health solutions, robotic surgical systems, and advanced surgical instruments, has increased the demand for comprehensive testing services. Additionally, manufacturers continue to invest heavily in quality assurance and regulatory compliance to meet evolving standards, ensure patient safety, and accelerate product approvals, further supporting market growth.

U.S. Market Trends

The U.S. is the major contributor to the medical device testing market, driven by its leadership in medical technology innovation and rigorous regulatory requirements. The U.S. Food and Drug Administration (FDA) requires extensive testing and validation before medical devices can enter the market, creating sustained demand for testing services. Furthermore, the rapid adoption of emerging technologies such as artificial intelligence-enabled medical devices, connected healthcare systems, robotic surgical platforms, and wearable health monitoring devices is increasing the need for specialized testing, safety assessments, and regulatory compliance services.

What Drives the Medical Device Testing Market in Europe?

Europe is expected to grow at a significant rate throughout the forecast years, owing to the increasing demand for healthcare services and advancements in medical device technology. The Medical Device Regulation (MDR) and the In Vitro Diagnostic Regulation (IVDR) put in place extensive testing and validation procedures before a product can be marketed. Demand for innovative medical technologies has been increasing as a result of the region's population ageing and increased prevalence of chronic diseases.

Germany Market Trends

In Germany, the market for medical device testing is experiencing substantial growth due to the country's advanced healthcare infrastructure, strong technological capabilities, and well-established regulatory environment. Germany is home to numerous medical device manufacturers, research institutions, and innovation centers that are actively developing next-generation healthcare technologies. Additionally, compliance with the MDR and IVDR has increased the demand for comprehensive testing services, including safety assessments, performance evaluations, biocompatibility testing, and clinical validation studies, further driving market growth.

What are the Key Trends in the Medical Device Testing Market in Latin America?

Latin America is expected to witness considerable growth in the medical device testing market, driven by increasing healthcare investments, expanding healthcare infrastructure, and growing adoption of advanced medical technologies across the region. Governments are actively working to improve healthcare quality and accessibility, which has increased the demand for medical device testing services to ensure product safety, efficacy, quality, and compliance with evolving regulatory standards.

Brazil Market Trends

Brazil represents the largest medical device market in Latin America. The country's expanding healthcare sector, rising adoption of innovative medical technologies, and evolving regulatory framework are driving demand for comprehensive testing services. To obtain market authorization from the Brazilian Health Regulatory Agency (ANVISA), medical device manufacturers must comply with stringent safety, performance, and quality requirements, further increasing the need for testing and certification activities.

How is the Opportunistic Rise of the Middle East & Africa in the Market?

The Middle East & Africa is expected to grow at a lucrative rate in the coming years, driven by ongoing healthcare modernization initiatives, supportive government policies, and increasing investments in healthcare infrastructure. The rising prevalence of chronic diseases, coupled with improved access to healthcare services, has led to greater adoption of advanced diagnostic and therapeutic medical devices. Furthermore, increasingly stringent regulations aimed at ensuring device safety, quality, and performance are boosting demand for testing, certification, and regulatory compliance services across the region.

UAE Market Trends

The UAE is emerging as a significant market for medical device testing, supported by its advanced healthcare infrastructure, evolving regulatory framework, and strong focus on healthcare innovation. The Ministry of Health and Prevention (MOHAP) oversees the approval of medical devices and ensures compliance with safety and quality standards. Growing investments in healthcare facilities, along with the increasing adoption of technology-driven medical solutions, are driving demand for comprehensive testing, validation, and certification services in the country.

Supply Chain Analysis-Medical Device Testing Market

• R&D: Research and development constitute the major factor in the medical device testing market, such as designing devices and selecting materials for development purposes, the creation of prototypes, and testing of devices.
  Key Players: Medtronic, Boston Scientific, Abbott, Siemens Healthineers, GE HealthCare
• Clinical Trials and Regulatory Approvals: To establish the safety, effectiveness, and quality of the device, a lot of testing is conducted in clinical trials and through the regulatory approval process.
  Key Players: Eurofins Scientific, SGS, Intertek Group, TÜV SÜD, Charles River Laboratories
• Patient Support and Services: Patient support services and post-market services include aspects such as adverse event (AE) reporting, collecting user feedback, etc., and include aspects of monitoring the performance of the device.
  Key Players: Philips Healthcare, Johnson & Johnson MedTech, Becton Dickinson (BD), Stryker, Zimmer Biomet

Competitive Landscape

The medical device testing market is moderately consolidated, with a mix of global testing service providers, specialized laboratories, and contract research organizations (CROs) competing to offer comprehensive testing solutions. Leading companies continue to strengthen their market positions by expanding capabilities in biocompatibility testing, chemical analysis, sterility assurance, and device performance evaluation. For example, in May 2026, researchers reported advancements in organ-on-a-chip technology, which has the potential to reduce reliance on animal testing by providing more accurate and efficient models for biomedical and medical device research.

Technological advancements such as artificial intelligence (AI), automation, and data analytics are playing an increasingly important role in shaping market growth and improving testing efficiency and accuracy. Companies are also pursuing strategic partnerships, mergers, acquisitions, and geographic expansion initiatives to broaden their service offerings and strengthen their market presence. Furthermore, collaborations among testing organizations, medical device manufacturers, and research institutions are accelerating innovation, supporting product development, and enhancing regulatory compliance across the industry.

Medical Device Testing Market Companies

• WuXi AppTec- A prominent player offers diverse medical device testing services, such as biocompatibility, chemistry, and microbiology testing.
• Intertek Group Plc- Its provisions primarily cover safety, performance, and compliance for different device types, from electrical and digital equipment to implantable and AI-assisted devices.
• Pace Analytical Services LLC- It enables various types of microbiology testing, functional and physical testing, and analytical chemistry.
• Eurofins Scientific- It is emphasising a new packaging testing lab and has boosted its ability to offer US and Canadian certifications for medical devices.
• North America Science Associates Inc. (NAMSA)- It is expanding its abilities in toxicology and sterility validation to assist the global medical device industry throughout the product lifecycle.
• Element Minnetonka: Specializes in high-cycle mechanical fatigue and durability testing for long-term cardiovascular and orthopedic implants, utilizing advanced linear motor-driven systems to simulate years of physiological stress on stents, heart valves, and grafts.
• Charles River Laboratories: Provides comprehensive preclinical contract research, including GLP-compliant biocompatibility assessments, rapid microbiology solutions like endotoxin testing, and specialized pathology services to evaluate device-tissue interactions.
• TÜV SÜD: Operates as a premier global Notified Body and certification organization, offering a "one-stop" suite for electrical safety (IEC 60601), electromagnetic compatibility (EMC), functional safety, and mandatory regulatory audits for global market access.
• Nelson Laboratories, LLC: Delivers industry-leading microbiological and analytical services, focusing on complex sterilization validations (EO, radiation, steam), packaging integrity/shelf-life studies, and cleaning validations for reusable surgical instruments.
• Laboratory Corporation of America Holdings (Labcorp): Leverages its vast clinical network to provide end-to-end device development support, ranging from early-stage non-clinical safety testing to global clinical trial management and post-market surveillance.
• SGS SA: Focuses on physical and technical compliance, providing global testing and certification for medical electrical equipment, including wireless technology verification, cybersecurity assessments, and environmental simulation testing.

Segments Covered in the Report

By Service Type

• Biocompatibility Tests
  • Cardiovascular Device's Biocompatibility Tests
  • Orthopedic Device's Biocompatibility Tests
  • Dental Implant Devices' Biocompatibility Tests
  • Dermal Filler's Biocompatibility Tests
  • General Surgery Implantation Devices Biocompatibility Tests
  • Neurosurgical Implantation Devices Biocompatibility Tests
  • Ophthalmic Implantation Device's Biocompatibility Tests
  • Others
• Chemistry Tests
  • Chemical characterization (E&L)
  • Analytical method development and validation
  • Toxicological Risk Assessment and consulting
• Microbiology & Sterility Test
  • Bioburden Determination
  • Pyrogen & Endotoxin Testing
  • Sterility Test & Validation
  • Antimicrobial Testing
  • Others
• Package Validation

By Phase Type

• Preclinical
• Large animal research
  • Biocompatibility Tests
  • Chemistry Test
  • Microbiology & Sterility Test
• Small animal research
  • Biocompatibility Tests
  • Chemistry Test
  • Microbiology & Sterility Test
• Clinical

By Geography

• North America
• Asia Pacific
• Europe
• Latin America
• Middle East & Africa